| Identification | More | [Name]
Vasopressin | [CAS]
11000-17-2 | [Synonyms]
VASOPRESSIN
adh(hormone)
leiormone
pitressin
pituitrin
tonephin
vasophysin
1-[19-amino-13-butan-2-yl-10-(2-carbamoylethyl)-7-(carbamoylmethyl)-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl]-N-[1-(carbamoylmethylcarbamoyl)-4-(diaminomethylideneamino)butyl]pyrrolidine-2-carboxamide
VASOPRESSIN ACETATE
VASOPRASSIN
Cys(1)-Tyr-Phe-Glu(NH2)-Asp(NH2)-Cys(1)-Pro-Xaa-Gly-NH2
Vasopressin Injection | [EINECS(EC#)]
200-050-5 | [Molecular Formula]
C46H65N13O12S2 | [MDL Number]
MFCD03839092 | [Molecular Weight]
1056.22 | [MOL File]
11000-17-2.mol |
| Hazard Information | Back Directory | [Uses]
Vasopressin is a peptide hormone that regulates the body’s retention of water. Vasopressin is an antidiurectic hormone. | [Veterinary Drugs and Treatments]
Vasopressin is used in veterinary medicine as a diagnostic agent and
in the treatment of diabetes insipidus in small animals. In recent
years, there has been significant interest in using vasopressin for
treating shock syndromes in humans and animals. Ongoing research
is being conducted.
In human medicine, vasopressin has been used to treat acute GI
hemorrhage and to stimulate GI peristalsis. Vasopressin CRI is also
being used for treatment of hypotensive septic patients unresponsive
to conventional vasopressor. Prior to radiographic procedures,
it has been used to dispel interfering gas shadows or help concentrate
contrast media. | [in vivo]
Vasopressin (0.03-0.3 μg/kg; i.p.) potentiates corticotropin release provoked by exogenous corticoliberin and increases corticotropin secretion subsequent to body water loss[2].
Vasopressin (0.001-0.1 mg/kg; i.p.) potently increases adjacent lying, where rats meeting for the first time lie passively next to each other[3]. | [IC 50]
Human Endogenous Metabolite |
|
| Company Name: |
Twochem Co.Ltd.
|
| Telephone: |
021-58111628 15800915896 |
| Website: |
cn.twochem.com |
|